• Home
  • About Us
  • Contact
  • Your Account
  • Subscribe
Tuesday, July 5, 2022
  • Login
Alternatives Watch
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
No Result
View All Result
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard
No Result
View All Result
Alternatives Watch
No Result
View All Result

Glenview Capital urges healthcare companies to create spin offs

Susan BarretobySusan Barreto
February 12, 2021
in Hedge Funds, Manager News
Glenview Capital urges healthcare companies to create spin offs

By serhiibobyk

ShareTweetShareSendSend

Glenview Capital’s Larry Robbins this week commented on proposed strategic spin-offs at Tenet Healthcare and Bausch Health Companies aimed at boosting shareholder value.

The $3.5 billion hedge fund is the largest shareholder of Tenet with a 15% stake in the company and confirmed its support of the board’s decision to spin-off the company’s Conifer subsidiary to shareholders in a tax-free transaction in mid-2022.

“We applaud the people of Tenet’s resilience and focus on the front lines of the battle against COVID-19, and we support management’s focus on worker and patient safety, operating efficiency and maximizing the number of patients who may be safely cared for throughout the pandemic,” said Glenview CEO Robbins in a statement.

He went on to say that Glenview believes that all shareholders will benefit from Tenet’s approach to spin-off Conifer, which specializes in revenue cycle management.  Conifer has reportedly been seen revenue losses as of late and according to Glenview the move will allow Tenet to continue to evolve its portfolio to higher ambulatory mix, while accelerating growth and generating cash.

In the case of Bausch Health Companies, Robbins made public a letter to the company CEO Joseph Papa. The aim is to force the company to move to spin-off its well-known eye-care franchise Bausch Global Eyecare.

Robbins wrote, “While the Company appears to be studying comprehensive solutions, the lack of progress has attracted legendary activist and value-investor Carl Icahn, whose engagement we welcome, but it has failed to attract many of the respected long-only institutions that traditionally anchor the top of the shareholder lists of leading healthcare businesses.”

On February 11, in a response to Carl Icahn’s pressure, Bausch’s board of directors and management team underscored its commitment to its intention to spin off Bausch & Lomb into an independent publicly traded entity, but said it remained open to pursuing all opportunities and paths to deliver value for shareholders.

“We remain strategically focused on executing our COVID-19 recovery plan, while capitalizing on key growth drivers and catalysts to grow EBITDA, improve working capital and delever our Company,” Bausch officials wrote. 

He elaborated that investors are fearful that the company will eventually be forced to sell cheap equity to reduce debt, which would put downward pressure on the share price. From there, Robbins laid out his own plan to provide a path for fellow shareholders to consider.

The detailed plan calls on Bausch to retain an investment bank to seek capital for up to a 40% equity stake in Bausch Global Eyecare prior to its spin-off. The raising of capital by selling a stake in the eyecare subsidiary at fair value is the alternative to selling any equity in the current holding company, whose fair value is currently higher than its current share price in Glenview’s opinion.

The capital infusion would allow for the creation of a new investment grade company and would begin to improve the credit ratios of the rest of Bausch Health Companies. Robbins said the firm believes the capital could come from a SPAC merger partner, private equity firm or even the IPO market.

A shareholder since 2018, currently Glenview Capital owns more than 21 million shares in Bausch Health Companies, which represents a 6% stake.

Tags: Life Sciences
ShareTweetShareSendSend
Previous Post

Melody and Pebblebrook partner on rooftop wireless investment

Next Post

Alto platform taps SkyBridge, other crypto fund managers

Related Posts

AW Top 10 reads for June
Hedge Funds

AW Top 10 reads for June

INPRS presses on with alts pacing plan
Hedge Funds

INPRS presses on with alts pacing plan

The pricing power of today’s tech-enabled investment office
Hedge Funds

The pricing power of today’s tech-enabled investment office

Franklin Templeton taps alts consultant
Hedge Funds

Franklin Templeton taps alts consultant

Michigan funnels $2bn-plus in Q1 alts investments
Hedge Funds

Michigan funnels $2bn-plus in Q1 alts investments

Next Post
Alto platform taps SkyBridge, other crypto fund managers

Alto platform taps SkyBridge, other crypto fund managers

Log In

Lost your password?

Recent

AW Top 10 reads for June

AW Top 10 reads for June

AW Deal Watch: Technology solutions shine with mega-sized take privates

AW Deal Watch: Technology solutions shine with mega-sized take privates

INPRS presses on with alts pacing plan

INPRS presses on with alts pacing plan

Search the AW Archives

No Result
View All Result

Download

Alternatives Watch

© 2019-2022, All Rights Reserved  |  BMV Digital

Navigate Site

  • Hedge Funds
  • Private Equity
  • Private Credit
  • RE/Infrastructure
  • Investor News
  • Research

Follow Us

No Result
View All Result
  • Hedge Funds
    • Manager News
    • Mandates
    • Service Provider News
    • CTAs/Managed Futures
  • Private Equity
    • Manager News
    • Mandates
    • Service Provider News
  • Private Credit
    • Manager News
    • Mandates
    • Service Provider News
  • RE/Infrastructure
    • Manager News
    • Mandates
    • Service Provider News
  • Investor News
    • Endowments and Foundations
    • ESG
    • Pensions
    • Platforms
    • Consultants
  • Research
    • Investor Scorecard
    • Manager Scorecard

© 2019-2022, All Rights Reserved  |  BMV Digital

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Be an alts insider

Start your days in the know with our free newsletter

No, I don't want to be an alts insider

Thank

You!

Follow us
on LinkedIn

Cookie Consent
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie Settings Accept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
Save & Accept
Powered by CookieYes Logo